查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1284224

到 2028 年的电生理学市场预测——按产品、适应症（房室结折返性心动过速、心房颤动、其他适应症）、最终用户和地区进行的全球分析

Electrophysiology Market Forecasts to 2028 - Global Analysis By Product, Indication (Atrioventricular Nodal Reentry Tachycardia, Atrial fibrillation and Other Indications), End User and By Geography
出版日期: | 出版商: Stratistics Market Research Consulting | 英文 175+ Pages | 商品交期: 2-3个工作天内

价格

根据 Stratistics MRC 的数据，2022 年全球电生理学市场规模将达到 75.7 亿美元，预计到 2028 年将达到 144.7 亿美元，预测期内復合年增长率为 11。预计增长速度为.4%。

电生理学 (EP) 是研究体内电活动的科学领域。 也称为侵入性心臟电生理学，它是一系列分析心臟电活动的测试。 它通过测量心臟的电系统和活动来诊断和治疗心律失常和心律失常。 该测试使用导管和线电极来评估通向心臟的血管的电活动。

根据 2022 年世界肥胖地图集，到 2030 年，美洲三分之一的男性 (34.41%) 和近五分之二的女性 (39.72%) 的 BMI 预计将达到 30 公斤/平方米。

市场动态

驱动程序：

心律失常、眼部问题和癫痫的患病率增加

由于冷冻消融、激光消融、超声消融和增强映射技术等创新技术的引入，预计全球电生理学市场在预测期内将会增长。 由于吸烟和过量饮酒等生活方式的选择，千禧一代心力衰竭 (HF) 和心臟骤停病例的增加也推动了市场的发展。 此外，EP 监测系统的小型化增加了全球电生理行业对这些设备的需求，尤其是在 COVID-19 期间。 因此，心律和残疾部门密切关注植入式电生理 (EP) 设备的远程监控和编程能力。

约束

成本高

建立 EP 实验室的成本多年来显着上升，原因包括医疗保健提供者的整合、复杂医疗程序的使用导致成本增加、政府法规不断变化以及资源限制等。 儘管各国对心律失常的认识和电生理产品在心律失常治疗中的作用不断增加，但这限制了这些产品的广泛使用。

机会

新兴市场增长

由于患者数量增加、心臟测绘系统普及、心血管疾病意识增强、可支配收入增加、医疗保健基础设施改善以及与发达国家相比相对宽鬆的指导方针，新兴市场正在蓬勃发展。预计将为这个市场的玩家。 在过去十年中，由于患者人数增加、心血管疾病相关死亡人数增加以及医疗旅游增加，新兴市场的外科手术数量稳步增加。

威胁

翻新设备

对翻新产品不断增长的需求对市场进入者，尤其是小型生产商构成了重大挑战。 为了提高市场地位并为电生理产品建立重要的用户群，市场参与者可能会降低价格或采用更好或更先进的技术来满足未满足的市场需求。

COVID-19 的影响：

COVID-19 的意外爆发对全球医疗器械业务产生了各种影响。 由于全球医院就诊人数下降，某些类别总体上受到了负面影响。 另一方面，感染 COVID-19 的既往心脏病患者更有可能发生心脏病发作或充血性心力衰竭。 这种减少限制了对电生理设备的需求并阻碍了市场增长。 此外，在市场上运营的主要市场参与者在 2020 年上半年见证了这些设备产生的收入下降。

预计 EP 实验室仪器部分在预测期内将成为最大的部分

EP 实验室仪器部门的推动因素包括用于开发新型电生理记录系统的公共和私人资金增加、射频消融手术数量的增加、射频消融手术与其他消融技术相比的成本效益、有利的增长是预计，部分原因是这些产品的可用性增加 EP 实验室设备进一步细分为 EP X 射线系统、3D 映射系统、EP 记录系统、EP 远程控制系统等。

房颤 (AF) 部分预计在预测期内的复合年增长率最高

房颤 (AF) 部分预计将在预测期内实现最高的复合年增长率。 心房颤动 (AF)，通常称为 AFib，是最常见的心律失常之一，会导致不规则、快速的心律。 在心房颤动中，心臟的上腔室迅速收缩，阻碍了血液从心房到心室的正常泵送，导致血栓形成。 房颤患者更容易出现严重的心臟问题，例如中风和心力衰竭。 据说心房颤动会导致大约六分之一的人中风。

市场份额最高的地区

由于不健康的生活方式以及吸烟和饮酒的增加导致心力衰竭、心臟骤停和心律失常的患病率上升，预计北美在预测期内将占据最大的市场份额。. 此外，该地区存在适当的报销政策也是推动市场扩张的主要因素之一。 在美国，大多数人肥胖且易患心血管疾病，这可能会促进市场增长。

复合年增长率最高的地区：

由于主要市场参与者在该地区国家/地区的活动增加，预计亚太地区在预测期内的复合年增长率最高。 在印度和中国等新兴国家，由于医疗保健基础设施的快速发展和可支配收入的增加，预计对电生理设备的需求将增加。 此外，医疗基础设施的快速发展和不断上升的医疗支出预计将推动该地区行业领先公司的投资。

主要发展：

2022 年 1 月，雅培获得了美国食品和药物管理局 (FDA) 对采用 EnSite 全极技术 (OT) 的 EnSite X EP 系统的许可。 它是一个新的心臟绘图平台，可在美国和欧洲使用，旨在帮助医生更好地治疗异常心律。 该系统创建了一个非常详细的心臟三维图，帮助医生识别出现异常节律的心臟区域，然后进行治疗。

2021 年 10 月，Boston Scientific, Inc. 达成最终协议，以 17.5 亿美元收购 Bayliss Medical Company, Inc.。 此次收购将有助于波士顿科学公司。

2020 年 12 月，Acutus 宣布在欧洲推出带有 CE 标誌的 AcQBlate 力传感消融系统。 AcQBlate 力传感消融系统采用市售的金头灌注力敏感射频消融导管设计，用于电生理标测和射频消融。

本报告内容

  • 区域和国家/地区细分市场份额评估
  • 向新进入者提出战略建议
  • 2020、2021、2022、2025 和 2028 年的综合市场数据
  • 市场趋势（驱动因素、制约因素、机会、威胁、挑战、投资机会、建议）
  • 根据市场预测在关键业务领域提出战略建议
  • 竞争格局映射关键共同趋势。
  • 公司简介，包括详细的战略、财务状况和近期发展
  • 映射最新技术进步的供应链趋势

免费定制优惠：

购买此报告的客户将获得以下免费定制选项之一：

  • 公司简介
    • 其他市场参与者的综合概况（最多 3 家公司）
    • 主要参与者的 SWOT 分析（最多 3 家公司）
  • 区域细分
    • 根据客户的要求对主要国家/地区的市场估计/预测/复合年增长率（注意：基于可行性检查）。
  • 竞争基准
    • 根据产品组合、区域影响力和战略联盟对主要参与者进行基准测试

内容

第 1 章执行摘要

第二章前言

  • 概览
  • 利益相关者
  • 调查范围
  • 调查方法
    • 数据挖掘
    • 数据分析
    • 数据验证
    • 研究方法
  • 调查来源
    • 主要研究来源
    • 二级研究来源
    • 假设

第三章市场趋势分析

  • 司机
  • 约束因素
  • 机会
  • 威胁
  • 产品分析
  • 最终用户分析
  • 新兴市场
  • COVID-19 的影响

第 4 章波特五力分析

  • 供应商的议价能力
  • 买家的议价能力
  • 替代品的威胁
  • 新进入者的威胁
  • 竞争公司之间的敌对关係

第 5 章全球电生理学市场：按产品分类

  • EP 实验设备
    • EP 远程转向系统
    • EP X射线系统
    • 3D 映射系统
    • EP录音系统
    • 其他 EP 实验室设备
  • EP 诊断导管
    • 固定诊断导管
    • 超声电生理诊断导管
    • 常规 EP 诊断导管
    • 可控诊断导管
    • 先进的电生理诊断导管
  • EP 消融导管
    • 常规高频消融导管
    • 高频消融导管
    • 灌注头高频消融导管
    • 激光烧蚀系统
    • 用于导航的高级地图配件
    • 微波消融系统
  • 访问设备
  • 其他产品

第 6 章全球电生理学市场：按适应症分类

  • 房室结折返性心动过速 (AVNRT)
  • 心房颤动 (AF)
  • 沃尔夫帕金森-怀特综合症 (WPW)
  • 心房扑动
  • 其他适应症

第 7 章全球电生理学市场：按最终用户分类

  • 门诊手术中心
  • 医院和心臟中心
  • 其他最终用户

第 8 章。全球电生理学市场：按地区

  • 北美
    • 美国
    • 加拿大
    • 墨西哥
  • 欧洲
    • 德国
    • 英国
    • 意大利
    • 法国
    • 西班牙
    • 其他欧洲
  • 亚太地区
    • 日本
    • 中国
    • 印度
    • 澳大利亚
    • 新西兰
    • 韩国
    • 其他亚太地区
  • 南美洲
    • 阿根廷
    • 巴西
    • 智利
    • 其他南美洲
  • 中东和非洲
    • 沙特阿拉伯
    • 阿拉伯联合酋长国
    • 卡塔尔
    • 南非
    • 其他中东和非洲地区

第九章主要进展

  • 合同、伙伴关係、协作和合资企业
  • 收购与合併
  • 新产品发布
  • 业务扩展
  • 其他关键策略

第10章公司简介

  • Japan LifeLine Co., Ltd.
  • MicroPort Scientific Corporation
  • Osypka Medical
  • Abbott
  • GE Healthcare
  • Siemens Healthcare GmbH
  • APN Health, LLC
  • Koninklijke Philips N.V.
  • Medtronic
  • Stereotaxis, Inc.
  • Johnson & Johnson
  • Japan LifeLine Co., Ltd.
  • Boston Scientific Corporation
  • Acutus Medical, Inc.
Product Code: SMRC23056

According to Stratistics MRC, the Global Electrophysiology Market is accounted for $7.57 billion in 2022 and is expected to reach $14.47 billion by 2028 growing at a CAGR of 11.4% during the forecast period. Electrophysiology (EP) is a scientific discipline that investigates electrical activity in the body. It is also known as invasive cardiac electrophysiology, and it is a series of tests that analyse the electrical activity of the heart. It is used to diagnose and treat cardiac rhythm disorders or arrhythmias by measuring the electrical system or activity of the heart. During the test, catheters and wire electrodes are utilised to assess electrical activity in blood vessels that lead to the heart.

According to the World Obesity Atlas 2022, 1 in 3 men (34.41%) and nearly two-fifths of women (39.72%) are expected to have a BMI of 30kg/m2 by 2030 in the Americas area.

Market Dynamics:

Driver:

The increasing prevalence of heart arrhythmias, ophthalmic issues, and epilepsy

The introduction of innovative technologies such as cryoablation, laser ablation, ultrasonic ablation, and enhanced mapping technologies is expected to increase the global electrophysiology market over the forecast period. The market is also being fueled by the increased prevalence of heart failure (HF) and cardiac arrest cases among millennials as a result of lifestyle choices such as smoking and excessive alcohol consumption. Furthermore, smaller EP monitoring systems have raised demand for these devices in the worldwide electrophysiology industry, particularly during the COVID-19 period. As a result, the cardiac rhythm and failure divisions are paying careful attention to remote monitoring and the programming capabilities of implanted electrophysiology (EP) devices.

Restraint:

High cost

The cost of constructing the EP laboratory has risen significantly over the years due to variables such as healthcare provider consolidation, growing expenses due to the usage of complicated medical treatments, changing government restrictions, and limited resources. This is limiting the penetration of these goods, despite the fact that knowledge of arrhythmia and the usefulness of electrophysiological products to treat arrhythmia is increasing in various nations.

Opportunity:

Rising number of emerging markets

Emerging markets are expected to offer significant growth opportunities for players in this market, owing to their increasing patient population, rising adoption of cardiac mapping systems, growing awareness of CVDs, rising disposable incomes, improving healthcare infrastructure, and comparatively lenient guidelines when compared to developed countries. During the last decade, emerging countries have seen a steady increase in the number of surgical procedures, driven by a larger target patient population, an increase in CVD-related fatalities, and increased medical tourism.

Threat:

Refurbished devices

The rising demand for refurbished products presents a significant challenge for market participants, particularly small producers. To enhance their market position and build a significant user base for their electrophysiological goods, market players must either drop their pricing or develop better or more advanced technologies that can answer the market's unmet needs.

COVID-19 Impact:

The unexpected breakout of the COVID-19 pandemic has had a mixed influence on the worldwide medical equipment business. Some categories suffered an overall negative impact as a result of the global drop in the number of patient visits to hospitals. Patients with pre-existing cardiac disease who are exposed to COVID-19, on the other hand, are more likely to experience a heart attack or develop congestive heart failure. The decline has led to limited demand for electrophysiology devices, hampering the growth of the market. Additionally, key market players operating in the market witnessed decline in the revenues generated from these devices in the first half of 2020.

The EP laboratory devices segment is expected to be the largest during the forecast period

The EP laboratory devices segment is estimated to have a lucrative growth, Due to the increasing public-private funding for the development of novel electrophysiology recording systems, the rising number of RF ablation procedures, the cost-effectiveness of RF ablation procedures in comparison to other ablation techniques, and the expanding availability of these products in major markets. EP laboratory devices are further subdivided into EP X-Ray systems, 3D mapping systems, EP recording systems, EP remote steering systems, and others.

The atrial fibrillation (AF) segment is expected to have the highest CAGR during the forecast period

The atrial fibrillation (AF) segment is anticipated to witness the highest CAGR growth during the forecast period. Atrial fibrillation (AF), commonly known as AFib, is one of the most prevalent kinds of arrhythmia, resulting in irregular and fast heart rhythms. It happens when rapid electric signals drive the upper chamber of the heart to contract quickly, preventing the atria from pumping blood into the ventricles regularly, resulting in blood clots. Atrial fibrillation patients are more likely to get serious heart issues such as strokes and heart failure. AFib contributes to nearly one in every six strokes.

Region with highest share:

North America is projected to hold the largest market share during the forecast period because of the rising prevalence of heart failure (HF), cardiac arrest, and cardiac arrhythmia as a result of unhealthy lifestyles and increased smoking and alcohol intake. The presence of proper reimbursement policies in the region is also one of the primary factors likely to drive market expansion. While the majority of the population in America is obese, they are predisposed to cardiovascular disease, which is likely to boost market growth.

Region with highest CAGR:

Asia Pacific is projected to have the highest CAGR over the forecast period, owing to increasing activities by key market players in countries in the region. The fast growth of healthcare infrastructure and rising disposable income in developing countries such as India and China are expected to drive up demand for electrophysiology devices. Furthermore, it is projected that top industry companies in the region will boost their investment due to the region's fast rising healthcare infrastructure and growing healthcare spending.

Key players in the market:

Some of the key players profiled in the Electrophysiology Market include Japan LifeLine Co., Ltd., MicroPort Scientific Corporation, Osypka Medical, Abbott, GE Healthcare, Siemens Healthcare GmbH, APN Health, LLC, Koninklijke Philips N.V., Medtronic, Stereotaxis, Inc., Johnson & Johnson, Japan LifeLine Co., Ltd., Boston Scientific Corporation and Acutus Medical, Inc.

Key Developments:

In January 2022, Abbott has received the U.S. Food and Drug Administration for its EnSite X EP System with EnSite Omnipolar Technology (OT). It is a new cardiac mapping platform available in the US and across Europe that is designed to help physicians better treat abnormal heart rhythms. The system creates highly detailed three-dimensional maps of the heart to help physicians identify and then treat areas of the heart where abnormal rhythms originate.

In October 2021, Boston Scientific Corporation has entered into a definitive agreement to acquire Baylis Medical Company Inc. for $1.75 billion. The acquisition will help Boston Scientific.

In December 2020, Acutus has announced the launch of their AcQBlate Force Sensing Ablation System in Europe after getting the CE Mark. The AcQBlate Force Sensing Ablation System, designed with commercially available gold-tipped, irrigated, force-sensing radiofrequency ablation catheter, it is used for electrophysiology mapping and RF ablation.

Products Covered:

  • EP laboratory devices
  • EP diagnostic catheters
  • EP ablation catheters
  • Access devices
  • Other Products

Indications Covered:

  • Atrioventricular Nodal Reentry Tachycardia (AVNRT)
  • Atrial fibrillation (AF)
  • Wolff-Parkinson-White Syndrome (WPW)
  • Atrial flutter
  • Other Indications

End Users Covered:

  • Ambulatory surgery centers
  • Hospitals & cardiac centers
  • Other End Users

Regions Covered:

  • North America
    • US
    • Canada
    • Mexico
  • Europe
    • Germany
    • UK
    • Italy
    • France
    • Spain
    • Rest of Europe
  • Asia Pacific
    • Japan
    • China
    • India
    • Australia
    • New Zealand
    • South Korea
    • Rest of Asia Pacific
  • South America
    • Argentina
    • Brazil
    • Chile
    • Rest of South America
  • Middle East & Africa
    • Saudi Arabia
    • UAE
    • Qatar
    • South Africa
    • Rest of Middle East & Africa

What our report offers:

  • Market share assessments for the regional and country-level segments
  • Strategic recommendations for the new entrants
  • Covers Market data for the years 2020, 2021, 2022, 2025, and 2028
  • Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
  • Strategic recommendations in key business segments based on the market estimations
  • Competitive landscaping mapping the key common trends
  • Company profiling with detailed strategies, financials, and recent developments
  • Supply chain trends mapping the latest technological advancements

Free Customization Offerings:

All the customers of this report will be entitled to receive one of the following free customization options:

  • Company Profiling
    • Comprehensive profiling of additional market players (up to 3)
    • SWOT Analysis of key players (up to 3)
  • Regional Segmentation
    • Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
  • Competitive Benchmarking
    • Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances

Table of Contents

1 Executive Summary

2 Preface

  • 2.1 Abstract
  • 2.2 Stake Holders
  • 2.3 Research Scope
  • 2.4 Research Methodology
    • 2.4.1 Data Mining
    • 2.4.2 Data Analysis
    • 2.4.3 Data Validation
    • 2.4.4 Research Approach
  • 2.5 Research Sources
    • 2.5.1 Primary Research Sources
    • 2.5.2 Secondary Research Sources
    • 2.5.3 Assumptions

3 Market Trend Analysis

  • 3.1 Introduction
  • 3.2 Drivers
  • 3.3 Restraints
  • 3.4 Opportunities
  • 3.5 Threats
  • 3.6 Product Analysis
  • 3.7 End User Analysis
  • 3.8 Emerging Markets
  • 3.9 Impact of Covid-19

4 Porters Five Force Analysis

  • 4.1 Bargaining power of suppliers
  • 4.2 Bargaining power of buyers
  • 4.3 Threat of substitutes
  • 4.4 Threat of new entrants
  • 4.5 Competitive rivalry

5 Global Electrophysiology Market, By Product

  • 5.1 Introduction
  • 5.2 EP laboratory devices
    • 5.2.1 EP remote steering systems
    • 5.2.2 EP X-Ray systems
    • 5.2.3 3D mapping systems
    • 5.2.4 EP recording systems
    • 5.2.5 Other EP laboratory devices
  • 5.3 EP diagnostic catheters
    • 5.3.1 Fixed diagnostic catheters
    • 5.3.2 Ultrasound EP diagnostic catheters
    • 5.3.3 Conventional EP diagnostic catheters
    • 5.3.4 Steerable diagnostic catheters
    • 5.3.5 Advanced EP diagnostic catheters
  • 5.4 EP ablation catheters
    • 5.4.1 Conventional radiofrequency ablation catheters
    • 5.4.2 Radiofrequency ablation catheters
    • 5.4.3 Irrigated-tip radiofrequency ablation catheters
    • 5.4.4 Laser ablation systems
    • 5.4.5 Navigational advanced mapping accessories
    • 5.4.6 Microwave ablation systems
  • 5.5 Access devices
  • 5.6 Other Products

6 Global Electrophysiology Market, By Indication

  • 6.1 Introduction
  • 6.2 Atrioventricular Nodal Reentry Tachycardia (AVNRT)
  • 6.3 Atrial fibrillation (AF)
  • 6.4 Wolff-Parkinson-White Syndrome (WPW)
  • 6.5 Atrial flutter
  • 6.6 Other Indications

7 Global Electrophysiology Market, By End User

  • 7.1 Introduction
  • 7.2 Ambulatory surgery centers
  • 7.3 Hospitals & cardiac centers
  • 7.4 Other End Users

8 Global Electrophysiology Market, By Geography

  • 8.1 Introduction
  • 8.2 North America
    • 8.2.1 US
    • 8.2.2 Canada
    • 8.2.3 Mexico
  • 8.3 Europe
    • 8.3.1 Germany
    • 8.3.2 UK
    • 8.3.3 Italy
    • 8.3.4 France
    • 8.3.5 Spain
    • 8.3.6 Rest of Europe
  • 8.4 Asia Pacific
    • 8.4.1 Japan
    • 8.4.2 China
    • 8.4.3 India
    • 8.4.4 Australia
    • 8.4.5 New Zealand
    • 8.4.6 South Korea
    • 8.4.7 Rest of Asia Pacific
  • 8.5 South America
    • 8.5.1 Argentina
    • 8.5.2 Brazil
    • 8.5.3 Chile
    • 8.5.4 Rest of South America
  • 8.6 Middle East & Africa
    • 8.6.1 Saudi Arabia
    • 8.6.2 UAE
    • 8.6.3 Qatar
    • 8.6.4 South Africa
    • 8.6.5 Rest of Middle East & Africa

9 Key Developments

  • 9.1 Agreements, Partnerships, Collaborations and Joint Ventures
  • 9.2 Acquisitions & Mergers
  • 9.3 New Product Launch
  • 9.4 Expansions
  • 9.5 Other Key Strategies

10 Company Profiling

  • 10.1 Japan LifeLine Co., Ltd.
  • 10.2 MicroPort Scientific Corporation
  • 10.3 Osypka Medical
  • 10.4 Abbott
  • 10.5 GE Healthcare
  • 10.6 Siemens Healthcare GmbH
  • 10.7 APN Health, LLC
  • 10.8 Koninklijke Philips N.V.
  • 10.9 Medtronic
  • 10.10 Stereotaxis, Inc.
  • 10.11 Johnson & Johnson
  • 10.12 Japan LifeLine Co., Ltd.
  • 10.13 Boston Scientific Corporation
  • 10.14 Acutus Medical, Inc.

List of Tables

  • Table 1 Global Electrophysiology Market Outlook, By Region (2020-2028) ($MN)
  • Table 2 Global Electrophysiology Market Outlook, By Product (2020-2028) ($MN)
  • Table 3 Global Electrophysiology Market Outlook, By EP laboratory devices (2020-2028) ($MN)
  • Table 4 Global Electrophysiology Market Outlook, By EP remote steering systems (2020-2028) ($MN)
  • Table 5 Global Electrophysiology Market Outlook, By EP X-Ray systems (2020-2028) ($MN)
  • Table 6 Global Electrophysiology Market Outlook, By 3D mapping systems (2020-2028) ($MN)
  • Table 7 Global Electrophysiology Market Outlook, By EP recording systems (2020-2028) ($MN)
  • Table 8 Global Electrophysiology Market Outlook, By Other EP laboratory devices (2020-2028) ($MN)
  • Table 9 Global Electrophysiology Market Outlook, By EP diagnostic catheters (2020-2028) ($MN)
  • Table 10 Global Electrophysiology Market Outlook, By Fixed diagnostic catheters (2020-2028) ($MN)
  • Table 11 Global Electrophysiology Market Outlook, By Ultrasound EP diagnostic catheters (2020-2028) ($MN)
  • Table 12 Global Electrophysiology Market Outlook, By Conventional EP diagnostic catheters (2020-2028) ($MN)
  • Table 13 Global Electrophysiology Market Outlook, By Steerable diagnostic catheters (2020-2028) ($MN)
  • Table 14 Global Electrophysiology Market Outlook, By Advanced EP diagnostic catheters (2020-2028) ($MN)
  • Table 15 Global Electrophysiology Market Outlook, By EP ablation catheters (2020-2028) ($MN)
  • Table 16 Global Electrophysiology Market Outlook, By Conventional radiofrequency ablation catheters (2020-2028) ($MN)
  • Table 17 Global Electrophysiology Market Outlook, By Radiofrequency ablation catheters (2020-2028) ($MN)
  • Table 18 Global Electrophysiology Market Outlook, By Irrigated-tip radiofrequency ablation catheters (2020-2028) ($MN)
  • Table 19 Global Electrophysiology Market Outlook, By Laser ablation systems (2020-2028) ($MN)
  • Table 20 Global Electrophysiology Market Outlook, By Navigational advanced mapping accessories (2020-2028) ($MN)
  • Table 21 Global Electrophysiology Market Outlook, By Microwave ablation systems (2020-2028) ($MN)
  • Table 22 Global Electrophysiology Market Outlook, By Access devices (2020-2028) ($MN)
  • Table 23 Global Electrophysiology Market Outlook, By Other Products (2020-2028) ($MN)
  • Table 24 Global Electrophysiology Market Outlook, By Indication (2020-2028) ($MN)
  • Table 25 Global Electrophysiology Market Outlook, By Atrioventricular Nodal Reentry Tachycardia (AVNRT) (2020-2028) ($MN)
  • Table 26 Global Electrophysiology Market Outlook, By Atrial fibrillation (AF) (2020-2028) ($MN)
  • Table 27 Global Electrophysiology Market Outlook, By Wolff-Parkinson-White Syndrome (WPW) (2020-2028) ($MN)
  • Table 28 Global Electrophysiology Market Outlook, By Atrial flutter (2020-2028) ($MN)
  • Table 29 Global Electrophysiology Market Outlook, By Other Indications (2020-2028) ($MN)
  • Table 30 Global Electrophysiology Market Outlook, By End User (2020-2028) ($MN)
  • Table 31 Global Electrophysiology Market Outlook, By Ambulatory surgery centers (2020-2028) ($MN)
  • Table 32 Global Electrophysiology Market Outlook, By Hospitals & cardiac centers (2020-2028) ($MN)
  • Table 33 Global Electrophysiology Market Outlook, By Other End Users (2020-2028) ($MN)

Note: Tables for North America, Europe, APAC, South America, and Middle East & Africa Regions are also represented in the same manner as above.